# Denali Therapeutics Inc. (DNLI)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DNLI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.60M | $ -256.00M | $ -231.48M | $ 27.51M | $ 835.18M |
| 2025 | $ 0 | $ -524.80M | $ -432.20M | $ 36.76M | $ 1.01B |
| 2024 | $ 0 | $ -444.37M | $ -382.18M | $ 48.71M | $ 1.23B |
| 2023 | $ 357.39M | $ -157.02M | $ -401.07M | $ 52.24M | $ 1.03B |
| 2022 | $ 121.16M | $ -364.17M | $ -293.30M | $ 60.35M | $ 1.04B |
| 2021 | $ 57.84M | $ -345.40M | $ -261.37M | $ 64.01M | $ 962.29M |
| 2020 | $ 427.61M | $ 90.62M | $ 526.21M | $ 68.87M | $ 1.15B |
| 2019 | $ 34.43M | $ -255.07M | $ -218.78M | $ 72.53M | $ 394.89M |
| 2018 | $ 170.58M | $ -47.86M | $ 61.71M | $ 0 | $ 546.85M |
| 2017 | $ 0 | $ -118.80M | $ -107.11M | $ 0 | $ 465.80M |
| 2016 | $ 0 | $ -119.22M | $ -107.99M | $ 0 | $ 254.52M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.39 |
| Current Ratio | 8.37 |

## Other views

- [Metrics](https://sponda.capital/en/DNLI.md)
- [Charts](https://sponda.capital/en/DNLI/charts.md)
- [Compare](https://sponda.capital/en/DNLI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.